Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Melanotan IIExplore study findings

What Five Skin Biopsies Showed After Reported Melanotan Exposure

1 numbered sourceSource years 2026

Peptides are amino acid chains held together by peptide bonds. Some stimulate receptors on melanocytes, the cells that make skin pigment. Melanotan II is a synthetic peptide that can activate those receptors. A 2026 dermatology case report described five melanomas found after a patient noticed that several existing moles had darkened during a period of reported melanotan use and indoor tanning. [1]

The patient had many moles and reported using both Melanotan II and a product described as Melanotan I. The clinicians biopsied the five lesions that looked most atypical, based on features including uneven shape, irregular borders and variation in color. A laboratory examination of the tissue found melanoma in situ in all five specimens. In situ describes disease confined to its original layer in the skin, with no invasion into the deeper tissue in the specimens examined. The biopsies established a diagnosis for the sampled lesions. Other moles were not biopsied in this report, so the five results do not describe all the patient's moles. [1]

The date a lesion darkens and the date a melanoma begins are different. The authors noted that the interval was short and that some lesions may already have been melanoma before the recent exposures made them more visible. The patient also reported tanning bed use over several years, recent tanning sessions during the same period and prior blistering sunburns. The products were not independently verified for composition. Those factors prevent the report from isolating any effect of Melanotan II. [1]

The case gives researchers a documented observation to investigate: existing pigmented lesions changed in appearance, and the selected lesions turned out to be malignant on biopsy. It does not provide a comparison group or a count of how many similarly exposed people did not develop melanoma. A study that measured exposure, ultraviolet history and diagnoses across comparable groups would be needed to estimate whether melanoma risk differs. The tissue findings are much more certain than any explanation for why the lesions were present. [1]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop Melanotan II

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.